Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China · Delayed Price · Currency is CNY 7.10
-0.10 (-1.39%)
Sep 2, 2026, 3:04 PM CST
SHE:002566 Revenue
Jilin Jian Yisheng Pharmaceutical had revenue of 159.87M CNY in the quarter ending June 30, 2026, a decrease of -5.23%. This brings the company's revenue in the last twelve months to 650.83M, up 0.37% year-over-year. In the year 2025, Jilin Jian Yisheng Pharmaceutical had annual revenue of 640.17M, down -4.23%.
Revenue (ttm)
650.83M
Revenue Growth
+0.37%
P/S Ratio
3.66
Revenue / Employee
393.01K
Employees
1,656
Market Cap
2.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 640.17M | -28.30M | -4.23% |
| Dec 31, 2024 | 668.47M | -185.20M | -21.69% |
| Dec 31, 2023 | 853.66M | 23.62M | 2.85% |
| Jan 1, 2023 | 830.04M | -47.89M | -5.45% |
| Jan 1, 2022 | 877.93M | 35.34M | 4.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.15B |
| Zhejiang East Asia Pharmaceutical | 990.47M |
| Guangdong VTR Bio-Tech | 814.07M |
| Guiyang Xintian Pharmaceutical | 723.26M |
| Landfar Bio-medicine | 660.26M |
| Hubei Goto Biopharm Group | 650.05M |
| Suzhou Fushilai Pharmaceutical | 394.29M |
| Yantai Zhenghai Biotechnology | 336.07M |